ファティ・アラファト (Fathi Arafat) は,ファティ・アラファト (Fathi Arafat) だった.

Same author

Nature Index 2015 Collaborations.

Nature·2015

Same author

Sickle-cell disease.

Nature·2014

Same author

Hiroshi Nakajima.

Lancet (London, England)·2013

Same author

Publishing: Open to possibilities.

Nature·2013

Same author

Basil Hetzel: vanquishing iodine deficiency disorders.

Lancet (London, England)·2013

Same author

Linda Bearinger: creating healthy pathways for adolescents.

Lancet (London, England)·2012

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

ファティ・アラファト (Fathi Arafat) は,ファティ・アラファト (Fathi Arafat) だった.

関連する概念動画

Nature Index 2015 Collaborations.

Sickle-cell disease.

Hiroshi Nakajima.

Publishing: Open to possibilities.

Basil Hetzel: vanquishing iodine deficiency disorders.

Linda Bearinger: creating healthy pathways for adolescents.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

ファティ・アラファト (Fathi Arafat) は,ファティ・アラファト (Fathi Arafat) だった.

関連する概念動画

関連記事

Nature Index 2015 Collaborations.

Sickle-cell disease.

Hiroshi Nakajima.

Publishing: Open to possibilities.

Basil Hetzel: vanquishing iodine deficiency disorders.

Linda Bearinger: creating healthy pathways for adolescents.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.